Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia

Off-Label Medication Use in Frontotemporal Dementia

(2010) Bei Hu et al.   American Journal of Alzheimers Disease and Other Dementias

Rational therapeutic approaches to progressive supranuclear palsy

(2010) M. Stamelou et al.   BRAIN

Frontotemporal Lobar Degeneration

(2010) Gil D. Rabinovici et al.   CNS DRUGS

Bapineuzumab

(2010) Geoffrey A Kerchner et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

MicroRNA-29b Regulates the Expression Level of Human Progranulin, a Secreted Glycoprotein Implicated in Frontotemporal Dementia

(2010) Jian Jiao et al.   PLoS One

Update on the use of memantine in Alzheimer’s disease

(2010) Rob Marum   Neuropsychiatric Disease and Treatment

Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

(2009) Ian R. A. Mackenzie et al.   ACTA NEUROPATHOLOGICA

An Open-label Study of Memantine Treatment in 3 Subtypes of Frontotemporal Lobar Degeneration

(2009) Adam L. Boxer et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

A new subtype of frontotemporal lobar degeneration with FUS pathology

(2009) M. Neumann et al.   BRAIN

Cholinesterase inhibition: is there evidence for disease-modifying effects?

(2009) Michael Shanks et al.   CURRENT MEDICAL RESEARCH AND OPINION

Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease

(2009) Gordon K. Wilcock et al.   JOURNAL OF CLINICAL PSYCHIATRY

Challenges in the conduct of disease-modifying trials in ad: Practical experience from a phase 2 trial of TAU-aggregation inhibitor therapy

(2009) C. Wischik et al.   Journal of Nutrition Health & Aging

Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

(2009) Kurt R. Brunden et al.   NATURE REVIEWS DRUG DISCOVERY

Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year

(2009) D. S. Knopman et al.   NEUROLOGY

Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia

(2008) Gil D. Rabinovici et al.   ANNALS OF NEUROLOGY

Development of methodology for conducting clinical trials in frontotemporal lobar degeneration

(2008) D. S. Knopman et al.   BRAIN

Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimers Disease

(2008) D. Munoz-Torrero   CURRENT MEDICINAL CHEMISTRY

New approaches to the treatment of frontotemporal lobar degeneration

(2008) Keith A Vossel et al.   CURRENT OPINION IN NEUROLOGY

Galantamine in Frontotemporal Dementia and Primary Progressive Aphasia

(2008) A. Kertesz et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

A 6‐month, open‐label study of memantine in patients with frontotemporal dementia

(2008) Janine Diehl‐Schmid et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease

(2008) Y. Matsuoka et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The logopenic/phonological variant of primary progressive aphasia

(2008) M. L. Gorno-Tempini et al.   NEUROLOGY

New directions for frontotemporal dementia drug discovery

(2007) John Q. Trojanowski et al.   Alzheimers & Dementia